Novo Nordisk and Vivani Medical are testing a small implant that releases semaglutide over several months, potentially ...

The yearlong trial found that the new drug was able to reduce HbA1c levels more than Ozempic.

GLP-1 weight loss drugs like Ozempic are linked to cosmetic concerns, including sagging earlobes, deflated breasts and flatter buttocks, surgeons say.

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

Australia could soon have a cheaper, needle-free alternative to Ozempic, with a weight-loss pill tipped for approval by ...

The once-a-day Wegovy pill hit UK high streets this week. It contains semaglutide, the active ingredient that’s in the ...

Millions of Americans on Medicare will have access to prescription weight loss medications for the first time starting July 1 ...

One simple thing could prevent people using the ‘miracle’ drugs from sustaining long-term health consequences.

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. While providers may prescribe this drug off label ...

Doctors have recently seen a trend where significant weight loss can leave the feet looking bonier, looser, or more deflated.

Serena Williams' weight loss is, in part, due to her use of GLP1s.